Keyphrases
Schizophrenic Patients
100%
Mental Illness
53%
Israel
51%
Schizophrenia
48%
Israeli
31%
Psychiatric Hospital
25%
Depressed Patients
25%
Inositol
23%
Psychiatrists
23%
Psychiatric Patients
23%
Placebo
21%
Chronic Schizophrenia
21%
First-night Effect
17%
Propranolol
17%
Autism
17%
Psychiatric Hospitalization
17%
Mental Hospital
16%
Lithium
16%
Hospitalization
15%
Medical Students
15%
Antidepressants
15%
Melatonin Treatment
14%
Clozapine
14%
Eating Disorders
14%
Spouses
14%
Mental Health
14%
Melatonin
14%
Antipsychotics
13%
Haloperidol
13%
Eye Movements
13%
Medical Records
13%
Length of Hospital Stay
13%
Psychiatric Services
12%
Serum Prolactin Level
11%
Electroconvulsive Therapy
11%
No Significant Difference
11%
Psychotic
11%
Psychiatric Inpatients
11%
Treating Physicians
11%
Major Depressive Disorder
11%
Clerkship
10%
Tardive Dyskinesia
10%
Mental Patients
10%
Positive Symptoms
10%
Agranulocytosis
9%
Illness
9%
Female Adolescents
9%
Judicial Decisions
9%
Attitudes toward Suicide
9%
Brainstem Auditory Evoked Potentials
9%
Neuroscience
Psychopathology
37%
Placebo
31%
Antipsychotic
24%
Rapid Eye Movement Sleep
21%
Autism
20%
Melatonin
18%
Antidepressant
16%
Positive Syndrome
15%
Eye Movement
15%
Inositol
14%
Clozapine
14%
Eating Disorder
14%
Major Depressive Disorder
14%
Propranolol
14%
Negative Syndrome
13%
Behavior (Neuroscience)
12%
Electroconvulsive Therapy
11%
Multiple Sclerosis
11%
Drug Therapy
11%
Haloperidol
11%
Tardive Dyskinesia
10%
Typical Antipsychotic
9%
Prolactin
9%
Evoked Brain Stem Auditory Response
9%
Interleukin 3
9%
Imipramine
9%
Interleukin 1
9%
Sensation of Hearing
9%
Treatment of Schizophrenia
9%
Platelet
9%
Blood Plasma
9%
Relapsing Remitting Multiple Sclerosis
9%
Bulimia Nervosa
8%
Mood Disorder
8%
Panic Disorder
7%
Autoantibodies
7%
Bipolar Disorder
7%
Slow-Wave Sleep
6%
Anorexia Nervosa
6%
Anxiety Disorder
6%
Arousal
6%
Akathisia
6%
Maprotiline
5%
Brainstem
5%
5-HT2 Receptor
5%
Neurotoxicity
5%
Tremor
5%
Wakefulness
5%
